This inventor holds 1 USPTO granted patent. Top assignee: King Saud University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Yasser Abbas Elnakady: Innovator in Anti-Cancer Compounds
Introduction
Yasser Abbas Elnakady is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Elnakady holds a patent for halogenated tetracyclic compounds, which are represented by a specific formula. These compounds are designed to serve as anti-cancer agents, showcasing his commitment to advancing medical science. The patent details that the compounds can exist in various forms, depending on the chemical structure, which enhances their therapeutic potential.
Career Highlights
Yasser Abbas Elnakady is affiliated with King Saud University, where he contributes to research and development in the field of pharmaceuticals. His academic background and research endeavors have positioned him as a key figure in the scientific community.
Collaborations
Elnakady has collaborated with notable colleagues, including Usama Sayed Eisa Karama and Mujeeb Abdullah Saeed Sultan. These partnerships reflect his dedication to collaborative research and innovation in the field of anti-cancer therapies.
Conclusion
Yasser Abbas Elnakady is a distinguished inventor whose work in anti-cancer compounds exemplifies the intersection of innovation and medical research. His contributions are vital to the ongoing fight against cancer, and his patent represents a significant step forward in therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile